Charge variants of proposed biosimilar to Omalizumab: Isolation, purification and analysis by HPLC methods.

Gupta, Tarun; Seshadri, Sriram

Gupta, Tarun; Seshadri, Sriram.

Afiliación

Gupta T; Institute of Science, Nirma University, 382481 Ahmedabad, Gujarat, India; Downstream Process Development, Kashiv BioSciences Pvt Ltd., 382210 Ahmedabad, Gujarat, India.
Seshadri S; Institute of Science, Nirma University, 382481 Ahmedabad, Gujarat, India. Electronic address: sriram.seshadri@nirmauni.ac.in.

Ann Pharm Fr ; 82(1): 64-71, 2024 Jan.

Article en En | MEDLINE | ID: mdl-37708991

Asunto(s)

Biosimilares Farmacéuticos; Omalizumab; Animales; Cromatografía Líquida de Alta Presión; Inmunoglobulina E; Cationes; Mamíferos

Palabras clave

Chromatographie; Chromatography; Des anticorps monoclonaux; Immunoglobulin E; Immunoglobuline E; Monoclonal antibodies; Potency; Puissance; Xolair

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Omalizumab Límite: Animals Idioma: En Revista: Ann Pharm Fr Año: 2024 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google